Novavax, Inc.
NVAX
•Stock Analysis$8.10
+0.00 (+0.00%)• Live
Novavax, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Novavax, Inc.
Key Financial Metrics
for Novavax, Inc.
P/E Ratio
2.42
Revenue Growth
+22.61%
EPS Growth
+77.26%
Market Cap
$1.17B
Dividend Yield
0.00%
Debt/Equity
-3.02
ROIC
+46.00%
FCF Yield
-16.85%
View additional metrics
Valuation
P/B Ratio-15.33
EV/Sales0.90
Financial Health
Current Ratio2.06
Return on Assets+40.53%
Analyst Recommendations
for Novavax, Inc.
22 analysts
Consensus: Buy
About
for Novavax, Inc.
Company Details
for Novavax, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
John Charles Jacobs
Employees
952
Market Cap
1.32B
Exchange
NASDAQ Global Select
IPO Date
December 5, 1995
Website
www.novavax.comCIK
0001000694
ISIN
US6700024010
CUSIP
670002401
Country
US
Balance Sheet
for Novavax, Inc.
Cash Flow Statement
for Novavax, Inc.
Income Statement
for Novavax, Inc.
News
No news available at the moment.